The technique of measuring thrombin generation with fluorescent substrates: 4. The H-transform, a mathematical procedure to obtain thrombin concentrations without external calibration

Summary

In fluorogenic thrombin generation (TG) experiments, thrombin concentrations cannot be easily calculated from the rate of the fluorescent signal increase, because the calibration coefficient increases during the experiment, due to substrate consumption and quenching of the fluorescent signal by the product. Continuous, external calibration via an in a parallel sample therefore was hitherto required for an accurate calculation of the TG curve. A technique is presented that allows mathematical transformation of experimental fluorescence intensities into “ideal” data, i.e. in the data that would have been obtained if substrate consumption and quenching by the product would not play a role. The method applies to fluorescence intensities up to 90% of the maximal fluorescent signal corresponding to total substrate conversion and thereby covers the entire region of interest encountered in practice. The first derivative of the transformed signal can then be converted into thrombin concentrations via a conventional, fixed calibration factor. This calibration factor can be obtained from a separate experiment but also by measuring the amidolytic activity of the α₂macroglobulin-thrombin complex present in the reaction mixture (“serum”) after thrombin generation is over. This method halves the amount of sample required per experiment.

Keywords

Thrombin generation - fluorogenic methods - calibration

• References

• 1 Varadi K, Negrier C, Berntorp E. et al. Monitoring the bioavailability of FEIBA with a thrombin generation assay. J Thromb Haemost 2003; 01: 2374-2380.
• 2 De Smedt E, Al Dieri R, Spronk HMH. et al. The technique of measuring thrombin generation with fluorogenic substrates: I. Necessity of adequate calibration. Thromb Haemost 2008; 100: 343-349.
• 3 Hemker HC, Giesen P, Al Dieri R. et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb 2003; 33: 4-15.
• 4 Holzhutter HG, Henke W. A new method of parameter estimation from progress curves. Biomed Biochim Acta 1984; 43: 813-820.
• 5 Kuttner GA, Holzhutter HG, Frommel C. The use of progress curves for the estimation of inactivation rate constants of enzymes. Biomed Biochim Acta 1985; 44: 1025-1034.
• 6 Palmier MO, Van Doren SR. Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect. Anal Biochem 2007; 371: 43-51.
• 7 Hemker HC, Willems GM, Beguin S. A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thromb Haemost 1986; 56: 9-17.
• 8 Abramowitz I, Stegun IA. Handbook of Mathematical Functions. National Bureau of Standards, Reprint: Dover Publications Inc.; 1964
• 9 Hemker HC, Hemker PW. Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate. 2008 Patent Application WO 08/093831.
• 10 Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost 1995; 74: 134-138.
• 11 Turecek PL, Varadi K, Keil B. et al. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiol Haemost Thromb 2003; 33: 16-22.
• 12 Hemker HC, Wielders S, Kessels H. et al. Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thromb Haemost 1993; 70: 617-624.
• 13 Hemker HC, Giesen PL, Ramjee M. et al. The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thromb Haemost 2000; 83: 589-591.
• 14 Giesen P, Hemker HC, Beguin S. et al. Diagnostic test for determining the concentration of transient biological activity in composite biological media. Patent Application. 2003 Patent Application WO 03/093831.
• 15 Meyer HD, Keller H. One-point recalibration of heterogeneous enzyme immunoassays with non-linear calibration curves. Clin Chem 1988; 34: 113-117.
• 16 Giesen P, Van Asten T. Method of determining enzymatic activity in biological media. 2007 Patent Application WO2007141023.
• 17 Silva LC, Trevisan MG, Poppi RJ. et al. Direct determination of propranolol in urine by spectrofluorimetry with the aid of second order advantage. Anal Chim Acta 2007; 595: 282-288.
• 18 Heller JH, Setlow RB, Mylon E. Fluorimetric studies on epinephrine and l-arterenol in plasma. Am J Physiol 1951; 166: 304-313.
• 19 Hayashi H, Kamata K. Method of determination of fluorescent substance and method of assay of enzyme activity. 1998 US patent 5792662.
• 20 Hemker HC, De Smedt E, Hemker PW. During coagulation, thrombin generation shifts from chemical to diffusional control. J Thromb Haemost 2005; 03: 2399-2400.